MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System

Immorta Bio Reports Successful Lung Cancer Growth Inhibition by Senolytic Immunotherapy SenoVax™

12 Jun 2024

Immorta Bio Inc, a science-based Life Extension company announced today positive preclinical...

The merger with NLS Pharmaceutics was approved by Kadimastem shareholders

Dr. Alastair Leighton, a biopharma veteran, has been hired as Chief Operating Officer by Chemify

At the PHPN 2025 Symposium, Corsair Pharma will present new data on its proprietary transdermal system for Treprostinil prodrug

Samsung Bioepis Announces the Launch of Denosumab Biosimilars, OBODENCE™ and XBRYK™, in Europe

Matisse Pharmaceuticals receives INN for M6229, recognizing it as a first-in-class drug, isupartob sodium

By Matisse Pharmaceuticals
Matisse Pharmaceuticals
15 Dec 2025

Sapio Sciences Collaborates with the Wellcome Sanger Institute on Transforming Digital Laboratories

By Sapio Sciences
Sapio Sciences
11 Dec 2025

Medra Raises $52 Million in Series A Funding to Build Physical AI Scientists

By Medra
Medra
11 Dec 2025

Voranigo® (vorasidenib) from Servier has received multiple regional Prix Galien Awards

By Servier
Servier
09 Dec 2025

FIZE Medical, in an exclusive deal with Asahi Kasei Medical, has launched the FIZE kUO® System in Japan

By FIZE Medical
FIZE Medical
09 Dec 2025

GMA with MOVIVA®: Setting New Standards in Endoscopic Bariatric Treatment.

By Erbe Elektromedizin GmbH
Erbe Elektromedizin GmbH
03 Dec 2025

The Digital Pharma Advances Conference 2026

Most Popular

Aptamer Sciences Inc.Innovative Liver Cancer Treatment AST-201

By Aptamer Sciences Inc.

Mar 25
Ouro Medicines launches to transform treatment for immune-mediated diseases with innovative therapies

By Ouro Medicines

Jan 10
Lutris Pharma secures $30 million in financing to advance the development of a biopharmaceutical aimed at improving the effectiveness of anti-cancer drugs

By Lutris Pharma

Jan 23

December 2025

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System

Immorta Bio Reports Successful Lung Cancer Growth Inhibition by Senolytic Immunotherapy SenoVax™

The merger with NLS Pharmaceutics was approved by Kadimastem shareholders

Dr. Alastair Leighton, a biopharma veteran, has been hired as Chief Operating Officer by Chemify

At the PHPN 2025 Symposium, Corsair Pharma will present new data on its proprietary transdermal system for Treprostinil prodrug

Samsung Bioepis Announces the Launch of Denosumab Biosimilars, OBODENCE™ and XBRYK™, in Europe

Matisse Pharmaceuticals receives INN for M6229, recognizing it as a first-in-class drug, isupartob sodium

Sapio Sciences Collaborates with the Wellcome Sanger Institute on Transforming Digital Laboratories

Medra Raises $52 Million in Series A Funding to Build Physical AI Scientists

Voranigo® (vorasidenib) from Servier has received multiple regional Prix Galien Awards

FIZE Medical, in an exclusive deal with Asahi Kasei Medical, has launched the FIZE kUO® System in Japan

GMA with MOVIVA®: Setting New Standards in Endoscopic Bariatric Treatment.

Most Popular

Aptamer Sciences Inc.Innovative Liver Cancer Treatment AST-201

Ouro Medicines launches to transform treatment for immune-mediated diseases with innovative therapies

Lutris Pharma secures $30 million in financing to advance the development of a biopharmaceutical aimed at improving the effectiveness of anti-cancer drugs

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe for e-Newsletter Monthly